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Thrombosis on the substrate of  a disrupted 
atheromatous plaque causes most acute coronary 
events. The physical integrity of the plaque, notably 
of  the extracellular matrix of  the fibrous capsule 
overlying the atheroma's thrombogenic lipid core, 
thus governs the most important clinical manifesta- 
tions of  atherosclerosis. Stable atheroma generally 
has thick fibrous caps and lipid pools smaller than 
lesions that have ruptured. Accumulating evidence 
supports akey role for inflammation as another crit- 
ical determinant of  the stability of  human athero- 
sclerotic plaques. Plaques that rupture generally 
have more abundant leukocytic infiltrates than 
those considered stable. Inflammatory mediators 
such as cytokines can influence several biological 
processes that regulate stability of  the plaque's 
fibrous cap, hence its resistance to rupture. For 
example, gamma interferon, produced by activated 
T lymphocytes within atheroma inhibits the pro- 
duction of interstitial forms of collagen by human 
vascular smooth muscle cells. Inf lammatory 
cytoldnes uch as interleukin-1, tumor necrosis fac- 
tor (TNF), and the cell surface homolog of TNF-a 
known as CD-40 ligand can also elicit the expres- 
sion by macrophages and smooth muscle cells of  
enzymes that can weaken the xtracellular matrix. 
Foam cells derived from both macrophages and 
smooth muscles also express active matrix-degrad- 
ing enzymes. We have hypothesized that lipid low- 
ering reduces timuli for the inflammatory response 
within the complicated atherosclerotic lesion. 
Classical studies in nonhuman primates uggested 
that lipid lowering produces qualitative changes in 
plaques more complex than mere "regression." 
Recent data from experimental studies in rabbits 
indicate that lipid lowering can reduce inflamma- 
tion in the atheroma, monitoring modern markers 
of vascular cell functions related to atheroma stabil- 
ity. In particular, lipid lowering by diet can reduce 
the number of  macrophages in plaques, and their 
expression of  such mediators of  plaque instability 
such as collagen-degrading matrix metallopro- 
teinases. Moreover, the collagen content of plaques 
increases during chronic lipid lowering, rendering 
plaques less friable and more resistant o rupture. 
After lipid-lowering smooth muscle cells in the 
plaque exhibit a more mature phenotype, using the 
expression of myosin isoforms as a molecular mark- 
cr. Macrophages and smooth muscle cells within 
plaques have reduced expression of  the potent pro- 
coagulant, tissue factor, a major instigator of  
thrombosis on disrupted atherosclerotic plaques. 
Such observations provide a mechanistic basis for 
understanding the marked reduction in acute coro- 
nary events observed in patients treated with agents 
that reduce their serum cholesterol levels. 
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Imaging techniques currently used to identify 
preclirdcal atherosclerotic lesions include measure- 
ment of carotid intima-media thickness (IMT) with 
B-mode ultrasound, coronary calcium scoring using 
electron beam computerized tomography (EBCT) 
or ultra-fast helical CT, endothelial function studies 
using B-mode ultrasound, and magnetic resonance 
imaging (MRI) of  the arterial wall. 1-6 With the 
exception of EBCT, each of  these technologies i
widely available in the clinical as well as the research 
setting. 
It is accepted that individuals with established 
coronary heart disease (CHD) benefit from aggres- 
sive medical intervention. Such intervention, termed 
secondary prevention, is directed at reducing mor- 
bidity and mortality in individuals at risk for recur- 
rent events. In contrast, primary prevention focuses 
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on the prevention of clinical symptoms in individu- 
als free of known CVD. Imaging technology may 
play an important role in this primary prevention 
effort by stratifying the risk of subsequent clinical 
events based on the presence or absence of preclini- 
cal lesions. On the basis of the strategy that healthy 
individuals at high risk for CVD also benefit from 
aggressive medical treatment, here may be substan- 
tial benefit from directing aggressive therapy at 
those in the higher risk categories and possible ben- 
efit from moderate therapy directed at those at mod- 
erate risk. The process by which risk factors are iden- 
tified and summated has been given such names as 
global risk assessment, coronary prediction algo- 
rithms, 10-year absolute risk, and calculated risk 
profile. Risk factors routinely used in such determi- 
nations include age, blood pressure, serum choles- 
terol (HDL  and LDL), diabetes, and cigarette 
smoking. Of  these, only age is not causally linked to 
the development of atherosclerosis. Rather, it serves 
to summate the impact of  risk factors over time. The 
appeal of imaging technology is that it can be used 
to directly quantitate the atherosclerotic burden, 
thus either supplementing or replacing age in the 
stratification of  risk. 7 
The additional information from imaging tech- 
nology to the basic risk information has been shown 
to substantially improve the ability to identify indi- 
viduals at risk for the development of CHD.8, 9 
The American Heart  Association convened a 
group to consider the status of a number of mea- 
sures of subclinical disease in CHD risk assessment. 
The conclusions of this group, named Prevention V
Writing Group, with regard to imaging studies were 
as follows: (1) The severity of  carotid IMT is an 
independent predictor of  transient cerebral ischemia, 
stroke, and coronary events such as myocardial 
infarction. In asymptomatic individuals over the age 
of 45, carefully performed carotid ultrasound exam- 
ination with IMT measurement can add incremental 
information to traditional risk factor assessment. (2) 
The extent o which coronary calcium scores predict 
coronary events independent of  the traditional coro- 
nary risk factors needs further study. The majority 
opinion was that until there is more definitive infor- 
mation about the additive value of calcium scores in 
the asymptomatic individual, coronary calcium mea- 
surement should not be recommended for routine 
risk assessment in asymptomatic populations. 
Selected use of  coronary calcium scores, when a 
physician is faced with a patient with intermediate 
coronary disease risk, may be appropriate. (3) MRI 
is a promising research tool, but its use appears lim- 
ited to only a small number of research laboratories 
at this time. The Writing Group concluded that 
MRI is not ready for application in the identification 
of  patients at high risk for CAD. (4) While the 
assessment of  endothelial function, as measured 
most typically by flow-mediated brachial artery 
vasodilatation, is a promising technique that may 
reflect an independent measure of CVD risk, addi- 
tional prospective research is needed to demonstrate 
that this technique can truly add to standard CHD 
or CVD risk prediction.l° 
Of these various imaging techniques, only carotid 
IMT measurements obtained with B-mode ultra- 
sound are currently recommended for inclusion in 
evaluation of risk. This is because several large multi- 
center prospective studies have shown that increases 
in carotid artery IMT are directly associated with an 
increased risk of incident myocardial infarction and 
stroke in adults without a history of  CVD, and 
carotid IMT is an independent predictor of CVD 
after adjustment for traditional risk factors. The writ- 
ing group of Prevention V identified two studies with 
strong data relating IMT measurement with incident 
CVD: the Atherosclerosis Risk in Communities 
(ARIC) Study, 8and the Cardiovascular Health Study 
(CHS). Having served at the Ultrasound Reading 
Center for CHS, I will focus on findings from that 
study. 
The Cardiovascular Health Study examined the 
associations between carotid artery IMT measured 
by high resolution sonography and incident myocar- 
dial infarction and stroke in 4476 individuals aged 
65 years or more without clinical cardiovascular dis- 
ease. 9 Cardiovascular events erved as outcome vari- 
ables over a median follow-up of 6.2 years. Carotid 
artery IMT measurements were shown to be associ- 
ated with incident cardiovascular events. The relative 
risk for incident myocardial infarction r stroke 
increased with IMT (P < .0001). The age/gender 
adjusted relative risk of  myocardial infarction r 
stroke for the highest quintile was 3.87 (2.72, 5.51; 
95% confidence intervals) as compared with the low- 
est quintile. The 7-year rates for myocardial infarc- 
tion and stroke were calculated by quintiles of the 
combined IMT measure. The estimated cumulative 
rate for myocardial infarction or stroke for partici- 
pants in the fifth quintile of IMT was over 25% at 7 
years, compared with a cumulative rate of less than 
5% for participants in the first quintile. The com- 
bined IMT measure was the variable most strongly 
associated with cardiovascular events after adjusting 
for conventional risk factors. A 1 SD increase in 
combined IMT measurement was associated with an 
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age- and a gender-adjusted relative risk of 1.36 for 
the combined end point of  myocardial infarction or 
stroke after adjustment for the other risk factors. 
This contrasts, in the same model, to a 1.34 increase 
in risk associated with a 1 SD (5.5 years) increase in 
age and a 1.21 increase in risk for a one SD change 
(21.5 mm Hg) in systolic blood pressure. The rela- 
tive strength of the associations between events and 
IMT as compared with the association between 
events and other traditional risk factors uggests that 
IMT, by itself, is as powerful a predictor of incident 
events as the traditional risk factors. 
It is probable that other imaging techniques will 
prove to be as strong or stronger predictors of risk as 
IMT. Large prospective studies are under way that 
will define the prognostic value worth of other non- 
invasive imaging tests to quantitate subclinical 
atherosclerosis. Cost has to be considered in deter- 
mining what best constitutes the basic building blocks 
of risk assessment profiling. Most traditional risk fac- 
tor measurements--age, blood pressure, smoking his- 
tory, diabetes--are available at little or no cost. 
Measurement of  IMT is currently in the range of 
$100 to $200. Coronary artery calcification measure- 
ment averages $400 to $500. While it is unclear 
exactly what MRI measurements will ultimately prove 
most useful, it is certain that the cost will be similar or 
higher than that for coronary artery calcification scor- 
ing. Against this must be weighed the expense of 
aggressively treating those who will likely derive little 
or no benefit from treatment, and not treating those 
who could well benefit. The issue then becomes the 
incremental precision that imaging brings to current 
risk profiling relative to the expense of obtaining that 
information. We can indeed image the early lesion 
with greater and greater precision. The question ow 
is when does it make sense to do so. 
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Rupture of the fibrous cap overlying the vulner- 
able plaque is the most common cause of coronary 
artery thrombosis. These atherosclerotic lesions 
have specific structural, cellular, and molecular char- 
acteristics that make them at high risk for rupture. 
Several of these characteristics of a vulnerable plaque 
include a thin fibrous cap overlying alarge lipid core, 
a soft core made of cholesteryl ester, inflammatory 
cell infiltrate, and cap irregularities. Identification of 
a plaque at risk for rupture would allow one to treat 
those lesions more aggressively. 
Multiple modalities including ultrasound, com- 
puted tomography, and magnetic resonance (MR) 
imaging have been used to help characterize and 
identify which plaques may be at risk. Most are able 
to measure vascular wall thickness or luminal nar- 
rowing. MR imaging is ideal for evaluating addi- 
tional characteristics of  the vulnerable plaque for 
several reasons. At small field of view, the in-plane 
resolution can be on the order ofmicrons, providing 
MR microscopy, or histology-like images of  these 
tissues. It provides imaging without ionizing radia- 
tion that can be repeated sequentially over time. It 
can differentiate plaque components on the basis of 
biophysical and biochemical properties such as 
